The type III secretion systems (T3SSs) are exploited by many Gram-negative pathogenic bacteria to deliver a set of effector proteins into the host cytosol during cell entry. The T3SS of Salmonella enterica serovar Typhimurium is composed of more than 20 proteins that constitute the membrane-associated base, the needle and the tip complex at the distal end of the T3SS needle. Membrane docking and piercing between the T3SS and host cells is followed by the secretion of effector proteins. Therefore, a secretion hierarchy among the substrates of the T3SS is required. The secretion of the pore-forming translocase proteins SipB, SipC and SipD is controlled by the T3SS regulator protein, InvE. During an attempt to identify the regions of InvE that are involved in T3SS regulation, it was observed that the secretion of SipB, SipC and SipD was inhibited when the C-terminal 52 amino acids were removed from InvE. In addition, InvE derivatives lacking the Nterminal 30 and 100 residues were unable to secrete translocases into the culture medium. Interestingly, in the absence of the N-terminal 180 residues of InvE, SipD is unstable, resulting in the hypersecretion of SipB. We also found that both the type III secretion signals of SipB and SptP were functionally interchangeable with the first 30 amino acids of InvE, which could allow the secretion of a reporter protein. These results indicate that InvE may have two functional domains responsible for regulating the secretion of translocases: an N-terminal secretion signal and a Cterminal regulatory domain.
INTRODUCTION
The type III secretion systems (T3SSs) in Gram-negative bacteria are important virulence factors that are responsible for the delivery of effector proteins into host cells. These proteins, in some intracellular pathogens, manipulate host cell signalling and vesicular trafficking to establish a replicative intracellular niche. The T3SS apparatus comprises a membrane-embedded basal body, an extracellular needlelike structure and a tip complex located at the top of the needle (Galán & Wolf-Watz, 2006; Hueck, 1998) . Upon contact with a host cell, translocases are immediately secreted and inserted into host cell membrane to form a translocation pore. Effector proteins are then translocated directly into the cytoplasm of the host cell (Matteï et al., 2011) . Because the translocation of effector proteins should only commence after the completion of the assembly of the translocation pore, it has been postulated that a secretion hierarchy between the translocases and effector proteins must be established to enable effective control of the translocation process Osborne & Coombes, 2011; Tree et al., 2009) . pathogenicity island (SPI)-1 and SPI-2. Both of these T3SSs are required at different stages of infection. During non-phagocytic cell invasion, the SPI-1 T3SS is activated and translocates several effector proteins into host cells to induce actin polymerization and membrane ruffling (Ly & Casanova, 2007) , while the SPI-2 T3SS is important for intracellular survival and replication within macrophages (Ochman & Groisman, 1996) . The SPI-1-associated protein InvE is essential for bacterial internalization and controls the secretion of translocases (SipB, SipC and SipD) of the SPI-1 T3SS (Ginocchio et al., 1992; Kubori & Galán, 2002) . In the invE mutant, the secretion of translocases is markedly decreased compared with their secretion in the wild-type, while effector proteins are efficiently secreted into the culture medium by both strains (Kubori & Galán, 2002) .
On the basis of evolutionary relationship and functional similarities among T3SS-related proteins in other bacteria, InvE is classified as a member of the gatekeeper family. This family includes MxiC from Shigella flexneri, the YopN-TyeA heterodimer from Yersinia pestis, SepL from enterohaemorrhagic Escherichia coli (EHEC) and enteropathogenic E. coli (EPEC), CopN from Chlamydia pneumoniae and SsaL from the SPI-2 T3SS of S. Typhimurium (Pallen et al., 2005) . MxiC is known to be involved in T3SS substrate switching. The deletion of the mxiC gene causes the impaired secretion of translocases IpaB and IpaC but results in the enhanced secretion of effector proteins without altering the T3SS assembly or the composition of the needle tip. This indicates that MxiC inhibits the access of effector proteins to the T3SS apparatus by an association with the ATPase Spa47 to prevent premature secretion of effector proteins (Botteaux et al., 2009) . When physical contact with a target cell occurs, the signal for this event is transmitted along the needle from the tip complex to the cytoplasmic domain of the T3SS apparatus, which results in the sequential secretion of MxiC and effector proteins (MartinezArgudo & Blocker, 2010) .
In contrast to MxiC or YopN, InvE is not secreted but is found in the cytoplasm and at the membrane, even though it does not have a transmembrane domain. This implies that InvE may transiently interact with the membrane or membrane-associated proteins of the SPI-1 T3SS (Kubori & Galán, 2002) . Recently, Lara-Tejero et al. (2011) reported that the secretion hierarchy between the translocases and effector proteins in the SPI-1 T3SS is established by a large complex that includes the SpaO-OrgA-OrgB sorting platform. It has also been determined that the T3SS-associated chaperones are responsible for the proper targeting of their cognate substrates to the sorting complex. In the absence of the invE gene, SipB, SipC and SipD are not associated with the SpaO-OrgA-OrgB complex. This indicates that InvE plays an important role in the loading of translocases onto the sorting platform. However, the regions of InvE that are involved in controlling the secretion of SPI-1 translocases remain unknown. In this study, we constructed a series of plasmids that encoded amino-or carboxyl-terminal truncations of InvE and showed that both terminal regions are critical for the type III secretion of translocases and for host cell invasion.
METHODS
Bacterial strains and growth conditions. All S. Typhimurium strains used in this study are listed in Table 1 . Unless otherwise noted, the bacteria were incubated at 37 uC in Luria-Bertani (LB) broth with 0.3 M NaCl for SPI-1 activation (SPI-1-inducing conditions). To induce the expression of the plasmid-encoded invE gene, L-arabinose was added to the bacterial culture at a final concentration of 0.2 % (w/ v). Antibiotics were added at the following concentrations: ampicillin (Ap; 100 mg ml 21 ), chloramphenicol (Cm; 30 mg ml 21 ), kanamycin (Km; 50 mg ml
21
) and tetracycline (Tc; 20 mg ml 21 ).
Construction of S. Typhimurium strains. All S. Typhimurium strains and primers used in this study are listed in Tables 1 and 2 . To construct the invE mutant, a disruption of the invE gene was performed using the method described by Datsenko & Wanner (2000) . Briefly, the chloramphenicol resistance gene (Cm r ) flanked by Flp recognition target sequences was amplified by PCR using pKD3 as a template with the muinvE-L and muinvE-R primer pair. The resulting PCR product was electroporated into the S. Typhimurium strain UK-1 carrying pKD46. This plasmid contains red lambda recombinase. The invE : : Cm (YKJ020) strain was selected by plating onto LB agar plates containing chloramphenicol. The insertion of the Cm r gene was verified by colony PCR and DNA sequencing. To eliminate polar effects on the downstream gene invA, the Cm r gene was removed by pCP20-encoded Flp recombinase, thus generating the DinvE mutant (YKJ021). The invEA : : Km (YKJ082) and the sipC : : Km (YKJ037) mutants were constructed in the same manner as the invE mutant, except that the kanamycin resistance gene (Km r ) was PCR-amplified from pKD4 with specific primer pairs (muinvE-L and muinvA-R for the invEA gene, and musipC-L and musipC-R for the sipC gene, respectively). To generate the DinvEA (YKJ087) and DsipC (YKJ038) mutants, the Km r genes in the invEA : : Km and sipC : : Km mutants were eliminated using pCP20. The removal of the target and Km r genes was verified by colony PCR. The DinvE fliGHI : : Tn10 (YKJ062) and DinvEA fliGHI : : Tn10 (YKJ132) strains were generated using P22-mediated transduction of the fliGHI : : Tn10 allele from M587 into the DinvE and DinvEA mutants, respectively. Phage-free transductants were purified on green plates (Chan et al., 1972) . The phage sensitivity was tested by cross-streaking with the clear-plaque mutant P22 H5 (a C2 2 mutant of P22). Transductions were verified by colony PCR and by the swarming motility assay. Epitope tagging of the sipD (sipD-HA, YKJ198), sptP (sptP-HA, YKJ119) and sipA (sipA-3FL, YKJ235) genes was performed with a described procedure (Uzzau et al., 2001) . The Cm r cassette of pSU314 was PCR-amplified using the tagsipD-HA-L and tagsipD-HA-R primer pair for the sipD gene and the tagsptP-HA-L and the tagsptP-HA-R primer pair for the sptP gene, and the resulting PCR product was integrated into S. Typhimurium strain UK-1. The sipD-HA allele from YKJ198 and the sipD : : Km allele from YKJ018 were transduced into the DinvE and DinvEA mutants to generate the DinvE sipD-HA (YKJ203), DinvEA sipD-HA (YKJ282) and DinvEA sipD : : Km (YKJ283) strains. The Km r cassette of pSUB11 was amplified by PCR using the tagsipA-3FL-L and tagsipA-3FL-R primer pair for the sipA gene, and the resulting PCR product was integrated into S. Typhimurium strain UK-1. The sipA-3FL allele from YKJ235 was transduced into sptP-HA strain (YKJ119) to generate sptP-HA sipA-3FL (YKJ278). The DinvE sptP-HA sipA-3FL (YKJ279) strain was generated by P22-transduction of the sptP-HA sipA-3FL allele from YKJ278 into the DinvE mutant. The phage sensitivity test was performed using P22 H5.
Construction of recombinant plasmids. All the plasmids and primers used in this study are listed in Tables 1 and 2 . To construct plasmid pinvE 1-372 -FL (pYKJ153), the full-length coding sequence for invE was PCR-amplified from the genomic DNA of S. Typhimurium strain UK-1 with the invE1-L and invE372-FL-R primer pair, where the latter primer sequence contains an internal SacI restriction site before the FLAG coding sequence. The PCR product was subsequently inserted into the EcoRI/PstI sites of the pBAD24 plasmid. This strategy was applied to the construction of the plasmid that expressed FL-InvE 1-372 (pYKJ260), except that the invE1-FL-L and invE372-R primer pair was used. To construct the invE variant plasmids, different lengths of the invE coding sequences were amplified by PCR using specific primers. These truncations were inserted in place of the full-length invE of pYKJ153 by cloning into the EcoRI/SacI sites. This resulted in the C-terminal FLAGtagged constructs. To construct the plasmids psipB 1-30 -invE 31-372 -FL (pYKJ274) and psptP 1-170 -invE 31-372 -FL (pYKJ275), each of the coding sequences for sipB, sptP and invE were PCR-amplified using the sipB1-L This study and sipB30-R primer pair for SipB 1-30 , the sptP1-L and sptP170-R primer pair for SptP , and the invE31-L2 and invE372-FL-R primer pair for InvE 31-372 -FL. These PCR products were cloned into the EcoRI/PstI sites of the pBAD24 plasmid. To construct the plasmids that encoded tetanus toxin fragment C (TTFC) fused to the N-terminal fragment of InvE, nonsecretable TTFC antigen (residues 2-119) was amplified by PCR from pTETnir15 (which encodes the full sequence of TTFC) with the TTFC-L and TTFC-FL-R primer pair. The resulting PCR product was digested using the XhoI/PstI restriction enzymes. The coding sequences of InvE 1-30 and InvE 1-100 were PCR-amplified using specific primers and were digested using EcoRI/XhoI restriction enzymes. Each of the PCR products was ligated into the EcoRI/PstI sites of the pBAD24 plasmid, thus generating the plasmids pinvE 1-30 -TTFC-FL (pYKJ271) and pinvE 1-100 -TTFC-FL (pYKJ272). The plasmid with an internal deletion of InvE (residues 31-100) was constructed by the inverse PCR method with the invE 30-R and invE101-L2 primer pair. The resulting PCR product was treated with DpnI before the digestion with BglII and then self-ligated, thereby generating plasmid pinvE D31-100 -FL (pYKJ262). The integrities of the resulting plasmid constructs were verified by DNA sequencing analysis.
Preparation of whole-cell proteins and secreted proteins of S.
Typhimurium. Overnight cultures of S. Typhimurium were diluted 1 : 20 in LB broth containing 0.3 M NaCl and grown at 37 uC until OD 600 0.8 was reached. L-Arabinose was then added, and the bacterial cultures were further incubated for 30 min. Cells were centrifuged at 8000 g for 10 min to separate the bacterial pellet from the culture supernatant. The resulting pellets were directly resuspended in 56 SDS sample buffer and boiled for 10 min. The supernatants were passed through a 0.45 mm filter and precipitated overnight with 10 % TCA (w/v) at 4 uC. The precipitate was washed with cold acetone and resuspended in PBS (Sigma) containing 80 mM Tris/HCl (pH 8.0). Equal amounts of whole-cell lysates and culture supernatant proteins were separated by SDS-PAGE, and the gels were subsequently silverstained or transferred onto nitrocellulose membranes for immunoblotting. Table 2 . Primer sequences used in this study
DUnderlined sequences in bold type indicate restriction enzyme recognition sites.
Regulation of type III secretion by InvE
Analysis of SipD stability. The sipD-HA DinvEA strain harbouring an InvE 181-372 -FL-encoding plasmid was grown at 37 uC under SPI-1-inducing conditions until OD 600 0.8 was reached. The culture was divided into two aliquots, one of which was supplemented with 0.2 % L-arabinose to induce InvE 181-372 -FL synthesis. After 30 min of further incubation, protein synthesis was blocked by the addition of 30 mg Cm ml 21 . Samples were taken at 10 min intervals and wholecell lysates were subjected to SDS-PAGE and immunoblotting.
Immunoblotting. Nitrocellulose membranes were blocked using Tris-buffered saline (pH 7.5) containing 0.1 % Tween-20 (v/v) (TBS-T) and 5 % (w/v) non-fat dried milk for 1 h. They were then incubated with the following primary antibodies at the appropriate dilutions in blocking solution for 1 h: a monoclonal anti-FLAG antibody (Sigma), a polyclonal anti-SipB antibody (Kim et al., 2007) , a polyclonal anti-haemagglutinin (HA) antibody (Santa Cruz Biotechnology) and a monoclonal anti-DnaK antibody (Enzo Life Sciences). After washing with TBS-T, the membranes were incubated with secondary horseradish peroxidase-conjugated goat anti-mouse or anti-rabbit IgG (both from Bio-Rad Laboratories) in blocking solution for 1 h. The membranes were then washed three times with TBS-T. Immunoblots were developed using a BM chemiluminescence blotting substrate (POD) (Roche), and the proteins were detected using an LAS-3000 image analyser (Fuji film). Blots were quantified using Image J software (NIH).
Invasion assay. The invasion assay was performed as described previously (Giacomodonato et al., 2007) . Briefly, the human epithelial cell line INT-407 was seeded at 2610 5 cells per well in a 24-well plate, and the cells were subsequently infected with the following S. Typhimurium strains at an m.o.i. of 10 for 45 min: the wild-type, the invE mutant and the isogenic mutant harbouring the invE-expressing plasmids. The cells were washed three times with fresh Dulbecco's modified Eagle's medium (DMEM) and further incubated in DMEM containing gentamicin (100 mg ml 21 ) for 90 min to kill the extracellular bacteria. After three washes with fresh DMEM, the invaded cells were lysed with 1 % (v/v) Triton X-100 in PBS for 15 min. The internalized bacteria were quantified by plating serial dilutions of the lysate onto LB agar plates.
Statistical analysis. The values are expressed as the mean±SD. The statistical significance was determined by one-way ANOVA with Tukey's post-hoc test using SPSS 12.0 software and is indicated by a P value. Differences were considered statistically significant when the P value was less than 0.05.
RESULTS

The C terminus of InvE is necessary for the secretion of SipB and SipC
The C-terminal domains in the InvE/MxiC/CopN/SepL/ YopN-TyeA family of proteins (TyeA in the case of the YopN-TyeA heterodimer) are important for regulating the secretion of translocases or effector proteins (Archuleta et al., 2011; Deane et al., 2008; Schubot et al., 2005; Wang et al., 2008) . To investigate whether the C terminus of InvE is involved in the regulation of SipB secretion, we constructed plasmids that encoded FLAG-tagged InvE containing full-length or C-terminal-truncated forms and introduced them into the DinvE mutant. In the culture supernatants of the DinvE mutant and the isogenic strain harbouring the plasmid expressing InvE 1-320 , the levels of SipB were dramatically decreased (Fig. 1a) . In contrast, the defect in SipB secretion in the DinvE mutant was complemented by a plasmid that expressed full-length InvE. These results indicate that the C-terminal FLAG tag did not affect the function of InvE and that the C terminus (residues 321-372) of InvE is necessary for the secretion of SipB. Nevertheless, we cannot rule out the possibility that InvE C-terminal deletion may cause misfolding, thus rendering the protein non-functional.
We subsequently examined whether the N terminus of InvE is also required for SipB secretion by constructing an InvE variant lacking the N-terminal 180 amino acids. Western blot analysis showed that although the intracellular level of SipB was slightly reduced in the DinvE mutant expressing InvE 181-372 , SipB was efficiently secreted into the culture supernatant (Fig. 1b) . In contrast, when the C-terminal region (residues 321-372) was additionally deleted, SipB was poorly secreted into the culture supernatant. Thus, the Nterminal 180 amino acids of InvE are not essential for the secretion of SipB. We also investigated the effect of the deletion of the C-terminal domain of InvE on the levels of SipC secretion, which has been demonstrated to be controlled by InvE (Kubori & Galán, 2002) . Consistent with the results shown in Fig. 1(a) , the levels of SipC in the culture supernatant were significantly decreased in the DinvE mutant harbouring C-terminally truncated InvE, whereas the secretion of effector protein SipA, which facilitates actin rearrangement for entry, was not affected by the C-terminal deletion of InvE (Fig. 1c) . These results demonstrate that the C terminus of InvE is specifically required for the secretion of the SipB and SipC translocases.
The C-terminal coiled-coil domain of InvE is not required for the secretion specificity of SipB
The proteins that are homologous to InvE, such as the YopN-TyeA heterodimer in Y. pestis and MxiC in Shigella flexneri, have coiled-coil domains in their C-terminal domains (Delahay & Frankel, 2002) . When the C terminus is deleted from these proteins, the secretion of the translocase and effector proteins is not regulated. We searched for a putative coiled-coil domain in InvE using the COILS server (http://www.ch.embnet.org/software/ COILS_form.html). This search predicted that InvE contains four putative coiled-coil domains at the following amino acid regions: Thr28-Ser42, Asp56-Asn80, Arg134-Asp158 and Ala356-Ser372 (see Fig. S1 available with the online version of this paper). To determine whether the coiled-coil domain in the C terminus of InvE contributes to the release of SipB, we constructed a series of InvE truncation mutants with every 10 amino acids sequentially deleted from position 320 to position 360. As shown in Fig.  2(a) , SipB was not efficiently secreted into the culture supernatant from the DinvE mutant harbouring plasmids expressing InvE 1-320 , InvE 1-330 , InvE 1-340 and InvE 1-350 , while InvE 1-360 recovered the SipB secretion. Furthermore, there appears to be a gradual decrease in the amount of SipB secretion as the C-terminal extension shortens. The same pattern of SipB secretion was also observed for InvE variants that lacked the N-terminal 180 amino acids, although SipB expression was slightly reduced compared with the wild-type strain (Fig. 2b) . These observations indicate that amino acids 321-360 of InvE are required for the secretion of SipB.
It has been shown that some type III secretion chaperones prevent the secretion of their cognate effector proteins by the flagellar export pathway, thereby ensuring the targeting of substrates to the cognate T3SS machinery (Lee & Galán, 2004) . Although SipB is secreted into the culture supernatant through the SPI-1 T3SS, the N-terminal 160 residues of SipB are secreted via the flagellar export were grown under SPI-1-inducing conditions. Whole-cell lysates and culture supernatants were analysed by immunoblotting with anti-SipB, anti-FLAG and anti-DnaK antibodies. The cytoplasmic protein DnaK was used as a control for cytoplasmic contamination of the culture supernatants. (c) UK-1, the DsipC mutant, the DinvE mutant and the isogenic mutant harbouring the plasmid expressing InvE 1-372 -FL and InvE 1-320 -FL were grown under SPI-1-inducing conditions. Secreted proteins from culture supernatants were analysed by silver staining. pathway, indicating that the N-terminal secretion signal of SipB can be recognized by both the SPI-1 T3SS and the flagellar T3SS (Kim et al., 2007) . Thus, we further investigated whether the deletion of the putative Cterminal coiled-coil domain (residues 356-372) of InvE might affect the specificity of the SipB secretion pathway. For this purpose, in the DinvE mutant background, we additionally deleted the invA gene, which encodes an essential component of the SPI-1 T3SS, or the fliGHI genes, which are required for flagellar assembly and flagellin secretion (Ehrbar et al., 2006) , resulting in the DinvEA mutant (defect in the SPI-1 T3SS) and the DinvE fliGHI : : Tn10 mutant (defect in the flagellar export pathway). Western blot analysis showed that SipB was present in the culture supernatant of the DinvE fliGHI : : Tn10 mutant, but not in that of the DinvEA mutant (Fig. 2c) . Taken together, these results indicate that SipB was secreted by the SPI-1 T3SS in S. Typhimurium expressing InvE 1-360 and that the last 12 amino acids (residues 361-372) that encompass the putative coiledcoil domain are dispensable for the type III secretion of SipB.
IP
InvE 181-372 allows for the secretion of translocases and effector proteins but fails to fully complement the invasion defect of the invE mutant
Because both SipB and SipC were found in the culture supernatant of the DinvE mutant harbouring the plasmid expressing InvE 181-372 , we hypothesized that this strain could invade host cells to a degree similar to the wild-type. To assess the bacterial invasion of non-phagocytic INT-407 cells, a gentamicin protection assay was performed. As shown in Fig. 3(a) , the defect in invasion of the DinvE mutant was restored by complementation with full-length InvE. However, the introduction of a plasmid that expressed InvE 181-372 could not fully complement the invasion defect of the invE mutant (6.5-fold less invasive than the wild-type). This defect was not due to the reduced secretion of T3SS effector proteins that are required for the invasion of non-phagocytic cells because a similar amount of SipA was detected from the culture supernatants of InvE 181-372 -expressing cells (Fig. 1c) . To confirm this result, we constructed S. Typhimurium strains in which SPI-1 effectors SipA and SptP were Cterminally tagged with 36FLAG and HA epitopes, respectively. Bacteria harbouring recombinant InvEexpressing plasmids were grown under SPI-1-inducing conditions and secreted proteins were subjected to SDS-PAGE and Western blotting. Fig. 3(b) shows that both SipA-3FL and SptP-HA were efficiently secreted in all strains, and that the levels of secreted SptP-HA in S. (Fig.  3c) . These results indicate that in S. Typhimurium expressing InvE 181-372 , SipB was secreted in an SPI-1 T3SS-dependent manner and that the N-terminal region of InvE is not involved in determining the secretion specificity of SipB.
Expression of InvE 181-372 results in a defect in SipD stability
As observed from the results above, the amount of SipB was reduced in the DinvE mutant harbouring the plasmid expressing InvE 181-372 , but sometimes the amount of SipB secretion was slightly increased compared with the wild-type. This pattern was similar to that observed for the sipD mutant (Kaniga et al., 1995) . Deletion of the sipD gene results in the enhanced secretion of SipB and SipC, but the sipD mutant is unable to invade non-phagocytic cells (Kaniga et al., 1995) . Based on these observations, we hypothesized that the N-terminal deletion of InvE might affect the expression or secretion of the SipD protein.
To address this question, we constructed strains in which the sipD gene was chromosomally tagged with an HA epitope at the C terminus. Western blot analysis in Fig. 4(a) showed that the secretion level of SipD-HA in the sipD-HA DinvE mutant was markedly decreased compared with that in the sipD-HA strain, which was consistent with an earlier result (Kubori & Galán, 2002) . However, the expression of InvE 181-372 in the sipD-HA DinvE mutant, compared with that of the full-length protein, caused dramatic reductions in the expression and subsequent secretion of SipD-HA. Next, we confirmed a defect in SipD stability in InvE 181-372 -expressing cells by the protein stability assay. In the absence of arabinose induction of InvE 181-372 , the intracellular level of SipD-HA was unchanged after the addition of chloramphenicol. In contrast, the level of SipD-HA in an arabinoseinduced culture was lower than that of the non-induced control and was rapidly decreased after chloramphenicol treatment (Fig. 4b) .
To determine whether the reduced intracellular SipB levels observed in InvE 181-372 -expressing cells were due to either its oversecretion or the instability of the protein, we examined the levels of SipB in the invA mutant background, in which SipB was accumulated in the cytoplasm without secretion into the culture supernatant. In the sipD-HA DinvEA mutant strain expressing InvE 181-372 , SipB was expressed and accumulated at a level similar to the non-induced control, whereas SipD-HA was hardly detected in whole-cell lysates (Fig. 4c) . Additionally, the expression of SipB was independent of SipD because SipB levels were not affected by the disruption of the sipD gene (sipD : : Km DinvEA). These results suggest that SipD is unstable in the presence of InvE 181-372 , and as a consequence, SipB is more readily secreted into the culture supernatant. The N-terminal polypeptides of InvE are responsible for the regulation of SipB secretion Because the secretion of MxiC is prerequisite for its function in Shigella flexneri, the non-secretable MxiC variant lacking an N-terminal secretion signal is unable to prevent the premature secretion of effector proteins (Botteaux et al., 2009) . To analyse the role of the Nterminal domain of InvE in SipB secretion, two plasmids that encode InvE 31-372 (D2-30) and InvE 101-372 (D2-100) were constructed and transformed into the sipD-HA DinvE mutant. As shown in Fig. 5(a) , SipB and SipD-HA were produced in similar amounts by these strains harbouring the full-length or N-terminal-truncated InvE. However, the secretion levels of SipB were markedly decreased in the culture supernatant of the sipD-HA DinvE mutant expressing InvE 31-372 and InvE . To further scrutinize the regulatory function of the InvE N terminus, we constructed a plasmid that encoded full-length InvE with an N-terminal FLAG tag (FL-InvE 1-372 ). Western blot analysis showed that SipB was expressed equally in the DinvE mutant that possessed the N-terminal-or C-terminal-tagged version of InvE, whereas the secretion level of SipB was dramatically decreased in the invE mutant harbouring the plasmid expressing FL-InvE 1-372 (Fig. 5b) . Taken together, these results indicate that the N-terminal 30 amino acids of InvE are required for SipB secretion.
InvE possesses a putative secretion signal in its N terminus
Because InvE without the first 30 amino acids failed to secrete SipB, we hypothesized that the N terminus of InvE may comprise a segment encoding a type III secretion signal and that the secretion signal of T3SS effector proteins can functionally replace the N terminus of InvE. We constructed two plasmids where the coding sequence of InvE 31-372 -FL was fused to the secretion signal of the T3SS-secreted proteins SipB (residues 1-30) and SptP (residues 1-170). Western blot analysis showed that the levels of expression and secretion of SipB from the DinvE mutant harbouring the plasmids expressing SipB 1-30 -InvE 31-372 -FL and SptP 1-170 -InvE 31-372 -FL were similar to those of the wild-type or the DinvE mutant complemented with the full-length InvE (Fig. 6a, b) .
It is known that the first 170 amino acids of SptP are targeted to the SPI-1 T3SS via an association with the chaperone protein SicP (Lee & Galán, 2004) , whereas the first 30 amino acids of SipB are secreted by a flagellar export pathway (Kim et al., 2007) . To investigate whether the SipB 1-30 region in SipB 1-30 -InvE 31-372 -FL affected the specificity of the secretion pathway of the translocase SipB, we transformed this plasmid into the DinvE, DinvEA, DinvE fliGHI : : Tn10 and DinvEA fliGHI : : Tn10 mutant strains. As shown in Fig. 6(b) , SipB was secreted by the DinvE and the DinvE fliGHI : : Tn10 strains, but it was not detected in the supernatants of the DinvEA and DinvEA fliGHI : : Tn10 strains. These results indicate that the translocase SipB is secreted through the SPI-1 T3SS even in the presence of the SipB 1-30 -InvE 31-372 -FL protein and that the N-terminal domain of InvE (residues 1-30) is functionally interchangeable with the secretion signals of some T3SS substrates.
Furthermore, in order to test whether the N terminus of InvE could serve as a secretion signal sufficient for the secretion of a reporter protein, we constructed two plasmids (pinvE 1-30 -TTFC-FL and pinvE 1-100 -TTFC-FL) in which the different N-terminal residues of InvE were fused to the coding sequence of TTFC (residues 2-119). This fragment would be secreted into the culture supernatant only when it was fused to the T3SS signal (Jang et al., 2012) . The first 30 amino acids of InvE were sufficient for the secretion of a fused TTFC protein into the culture supernatant, whereas when TTFC protein was fused to the N-terminal 100 amino acids of InvE, it was not secreted (Fig. 6c) . Next, to test whether residues 31-100 of InvE would block its secretion, we constructed a plasmid encoding an internal deletion in the invE gene (pinvE D31-100 -FL) and introduced the resulting plasmid into the wildtype strain. Fig. 6 (c) shows that InvE D31-100 was expressed in the cytoplasm but not secreted into the culture supernatant. These results indicate that InvE has a putative secretion signal within the first 30 N-terminal residues, although the secretion of the full-length of InvE may be blocked by the remaining region.
DISCUSSION
Salmonella enterica is the aetiological agent of either selflimiting gastroenteritis or life-threatening typhoid fever, which results in over 200 000 deaths annually worldwide (Crump & Mintz, 2010) . A major virulence determinant of S. Typhimurium is an SPI-encoded T3SS. After contact with the host cell, the translocase proteins SipB, SipC and SipD constitute the tip complex at the distal end of the T3SS needle, through which a set of effector proteins are delivered directly into the host cytoplasm (Galán & WolfWatz, 2006; Lara-Tejero & Galán, 2009) . In this study, we showed that both the N-and C-terminal regions of InvE are required for the secretion of translocases, which may coordinate the hierarchical secretion of translocases and effectors in S. Typhimurium. . This leads to the oversecretion of SipB and SipC into the culture supernatant but causes a defect in the invasion of INT-407 epithelial cells, a phenotype which is similar to that of the sipD mutant (Kaniga et al., 1995) . However, the truncation of the first 30 or 100 residues from InvE did not affect the expression of SipD, which indicates that specifically InvE181-372 has a negative effect on SipD stability, even though InvE does not interact directly with SipD (Kubori & Galán, 2002) . In Shigella flexneri, the signal of host cell contact is transmitted through a T3SS needle, leading to MxiC release and subsequently to secretion of effectors (Martinez-Argudo & Blocker, 2010) . However, as InvE is a non-secretable protein, a different mechanism would be needed to trigger effector secretion. Recently, we found that the N terminus of InvE is proteolytically degraded and that InvE 1-372 is less stable than InvE 181-372 (J. S. Kim and Y. K. Park, unpublished data) . This indicates that after host-cell sensing, the proteolysis of InvE at its N terminus may result in the rapid degradation of SipD, promoting the secretion of SPI-1 effectors. Further research is needed to elucidate the actual mechanism.
In contrast to the T3SS-secreted proteins Shigella MxiC, Yersinia YopN and Chlamydia CopN (Botteaux et al., 2009; Cheng et al., 2001; Fields & Hackstadt, 2000) , EPEC SepL and Salmonella InvE are not secreted but are broadly distributed in the cytoplasm and at the membrane (Deng et al., 2005; Kubori & Galán, 2002) . However, Younis et al. (2010) showed that proteins fused to the N terminus of SepL can be secreted and translocated. It has been reported that computational simulations performed using the Nterminal peptides of SPI-1 secreted substrates predict the existence of a putative secretion signal in the N terminus of InvE (Samudrala et al., 2009) . In this study, we found that deletion of the N-terminal amino acid residues of InvE and interference with the putative secretion signal by an Nterminal FLAG tag resulted in the invE mutant phenotype. In addition, the N-terminal 30 amino acids of InvE were functionally complemented with the secretion signals of the SPI-1 translocase or effector proteins and were able to deliver the bystander reporter protein TTFC to the culture supernatant. These data indicate that InvE also contains a putative secretion signal within its N terminus, although it remains in the cytoplasm. However, the secretion defect of full-length InvE seems unrelated to interactions with its binding partner proteins (such as SicA, SipB and SipC), because InvE was not secreted into the culture supernatant in the sicAsipBC mutant (data not shown). As type III secretion substrates must be maintained in the unfolded state before secretion, the secretion defect of the InvE protein may be attributed to structural factors in residues 31-372 such as compact folded conformation or interaction with the binding partners. However, additional research is needed to determine the conformation of InvE in the bacterial cytoplasm.
During culture of S. Typhimurium under SPI-1-inducing conditions, the full-length SipB (SipB 1-593 ) is secreted into the culture medium through the SPI-1 T3SS, whereas the secretion of the N-terminal 160 amino acids of SipB (SipB 1-160 ) is mediated by a flagellar export pathway (Kim et al., 2007) . Although SicA, which is a chaperone for SipB and SipC, could bind to SipB 1-160 , SicA or the SicAbinding domain is not involved in the targeting of SipB to the SPI-1 T3SS. However, when the C-terminal fragment (residues 301-593) of SipB is added to SipB 1-160 , the secretion specificity of this truncated protein (SipB D161-300 ) is returned to the original SPI-1 T3SS pathway (Kim et al., 2007) . These data indicate that SipB secretion via the SPI-1 T3SS pathway is mediated by its C-terminal domain, which may be recognized by a regulatory molecule such as InvE because the secretion of SipB D161-300 is impaired in the DinvE mutant (J. S. Kim and Y. K. Park, unpublished data) . However, InvE does not appear to confer specificity for the secretion pathway of SipB because we found that although the secretion level of SipB in the DinvE mutant was significantly reduced, the secretion itself was mediated by the SPI-1 T3SS (Fig. S2 ). This indicates that InvE is not a pilot protein that targets translocases to the SPI-1 T3SS but may play a role as a gatekeeper protein which allows the secretion of translocases possessing the 'key' domain recognized by InvE.
In summary, our data demonstrate that the N-terminal and C-terminal regions of InvE are important for the secretion of the SPI-1 translocases and that InvE possesses a potential secretion signal at its N-terminal domain.
